Science/Research reporter

Lisa Krieger

Lisa M. Krieger is a Bay Area News Group science writer for The Mercury News and East Bay Times, covering research, scientific policy and environmental news from Stanford University, the University of California, NASA-Ames, U.S. Geological Survey and other Bay Area-based research facilities. She graduated from Duke University with a BA degree in biology. She splits her time between Palo Alto and Inverness, and in her spare time likes wildlife photography, swimming, skiing and backpacking.

The potential treatment, called EBT-101, is safe and caused no major side effects, Excision BioTherapeutics reported at a meeting in Brussels.

SUBSCRIBER ONLY

Health |
CRISPR could kill HIV. But we don’t know if it’s a cure.

October 31, 2023 at 2:45 p.m.

The potential treatment, called EBT-101, is safe and caused no major side effects, Excision BioTherapeutics reported at a meeting in Brussels.

After years of blood transfusions, "they think getting cured is totally normal," said Alissa Finlayson.

SUBSCRIBER ONLY

Health |
A pioneering gene therapy aims to free patients of blood disease. Is a cure at hand?

October 26, 2023 at 2:45 p.m.

After years of blood transfusions, "they think getting cured is totally normal," said Alissa Finlayson.

Brain scans reveal why some patients with frontotemporal dementia show a burst of visual creativity.

SUBSCRIBER ONLY

Health |
How a rare dementia unleashes creativity

July 24, 2023 at 2:23 p.m.

Brain scans reveal why some patients with frontotemporal dementia show a burst of visual creativity.

Soft and flexible electronics are bringing artificial “skin” closer than ever to reality.

Health |
Stanford team makes electronic skin that can sense touch

June 2, 2023 at 8:23 a.m.

Soft and flexible electronics are bringing artificial “skin” closer than ever to reality.

Coming soon: EVs that are equipped to not just receive power, but also deliver it. A Santa Cruz Mountains woman's improvised system points the way forward.

Business |
How your car can power your home

April 17, 2023 at 5:36 p.m.

Coming soon: EVs that are equipped to not just receive power, but also deliver it. A Santa Cruz Mountains woman's improvised system points the way forward.

Rewriting the rules of reproduction, scientists have created mice with two dads. Could humans be next?

Two dads, one baby? Gene technique works in mice

April 10, 2023 at 4:06 p.m.

Rewriting the rules of reproduction, scientists have created mice with two dads. Could humans be next?

At airports, facial recognition helps improve security and efficiency. But it has privacy ramifications.

Travel |
Facial recognition at Bay Area airports: What you need to know

March 8, 2023 at 5:46 p.m.

At airports, facial recognition helps improve security and efficiency. But it has privacy ramifications.

Which is more dangerous -- COVID-19 variants omicron or delta? Here's what research suggests, so far.

Health |
Omicron vs. Delta: Comparing COVID’s most worrisome variants

December 5, 2021 at 10:02 p.m.

Which is more dangerous -- COVID-19 variants omicron or delta? Here's what research suggests, so far.

A COVID-19 vaccine produced by Johnson & Johnson — the company best known for producing band aids — is safe and effective, according to a Food and Drug Administration review released Wednesday, paving the way for a third U.S. vaccine.

How the new one-dose COVID-19 vaccine compares to Pfizer and Moderna

February 26, 2021 at 3:24 p.m.

A COVID-19 vaccine produced by Johnson & Johnson — the company best known for producing band aids — is safe and effective, according to a Food and Drug Administration review...